PubMed日本語 - 精神衛生を増進して、治療家で痴呆のある人々の間に抗精神病薬を減らす最適化された人中心の介入の事前調査:無作為比較試験のためにプロトコルを研究する。―QLifePro医療翻訳医療翻訳 QLifePro


Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial.


Published date



Rhiannon Whitaker, Clive Ballard, Jane Stafford, Martin Orrell, Esme Moniz-Cook, Robert T Woods, Joanna Murray, Martin Knapp, Barbara Woodward Carlton, Jane Fossey


Psychological Services, Oxford Health NHS Foundation Trust, Fulbrook Centre, Oxford OX3 7JU, United Kingdom.


BACKGROUND: People living in care homes often have complex mental and physical health problems, disabilities and social needs which are compounded by the use of psychiatric and other drugs. In the UK dementia care is a national priority with a vast impact on services. WHELD combines the most effective elements of existing approaches to develop a comprehensive but practical intervention. This will be achieved by training care staff to provide care that is focused on an understanding of the individual and their needs; and by using additional components such as exercise, activities and social interaction to improve mental health and quality of life (QoL) and reduce the use of sedative drugs.


DESIGN: Work Package 3 (WP3) is the pilot randomised trial and qualitative evaluation to help develop a future definitive randomised controlled clinical trial. The study design is a cluster randomised 2x2x2 factorial design with two replications in 16 care homes. Each care home is randomized to receive one of the eight possible permutations of the four key interventions, with each possible combination delivered in two of the 16 homes. Each cluster includes a minimum of 12 participants (depending upon size of the care home, the number of people with dementia and the number consenting).


DISCUSSION: The overarching goal of the programme is to provide an effective, simple and practical intervention which improves the mental health of, and reduces sedative drug use in, people with dementia in care homes and which can be implemented nationally in all UK care homes as an NHS intervention.


TRIAL REGISTRATION: Current controlled trials ISRCTN40313497.






460万語の専門辞書を備えた医療者専用翻訳サービス QLifePro医療翻訳